MMSI250117P50000
- 0.00
- 0.000.00%
Merit Medical Systems Newsroom
Merit Medical Is Maintained at Overweight by Piper Sandler
Merit Medical Systems Analyst Ratings
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $114
Sidoti Initiates Merit Medical Systems(MMSI.US) With Buy Rating, Announces Target Price $122
Sidoti Reaffirms Their Buy Rating on Merit Medical Systems (MMSI)
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Strong Operational Performance and Strategic Advancements Lead to Buy Rating for Merit Medical Systems
Merit Medical Price Target Maintained With a $109.00/Share by Needham
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $120
Merit Medical Systems Analyst Ratings
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $114
Merit Medical Is Maintained at Outperform by Raymond James
Raymond James Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $110
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $114
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Merit Medical Systems Analyst Ratings
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)